News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Intravenous PCA with hydromorphone outperforms oral morphine for severe cancer pain
08 Oct 2024
byJairia Dela Cruz
In the management of severe cancer pain, intravenous patient-controlled analgesia (PCA) with hydromorphone delivers superior pain control with greater patient satisfaction as compared with conventional oral morphine, according to the phase III open-label SYLT-021 study.
08 Oct 2024

Cemiplimab improves 5-year survival in advanced NSCLC
08 Oct 2024
byStephen Padilla
First-line cemiplimab monotherapy continues to provide durable overall (OS) and progression-free survival (PFS) benefits at 5 years compared with chemotherapy in advanced nonsmall cell lung cancer (NSCLC) patients with PD-L1 expression ≥50 percent, according to the results of the EMPOWER-Lung 1 study presented at WCLC 2024.
08 Oct 2024







